Compile Data Set for Download or QSAR
Report error Found 1026 for UniProtKB: P67870
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
Affinity DataKi:  0.220nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50335638(5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-...)
Affinity DataIC50: 0.300nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMedPDB3D3D Structure (crystal)
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484569(CHEMBL1934184)
Affinity DataIC50: 0.400nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484568(CHEMBL1934181)
Affinity DataIC50: 0.5nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM152738(5-(4-chlorophenyl)benzo[c]2,6-naphthyridine-8-carb...)
Affinity DataIC50: 0.5nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484577(CHEMBL1934182)
Affinity DataIC50: 0.5nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484567(CHEMBL1934180)
Affinity DataIC50: 0.600nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484579(CHEMBL1934166)
Affinity DataIC50: 1nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484584(CHEMBL1934318)
Affinity DataIC50: 1nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484556(CHEMBL1934160)
Affinity DataIC50: 1.10nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484563(CHEMBL1934173)
Affinity DataIC50: 1.20nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484558(CHEMBL1934164)
Affinity DataIC50: 1.30nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484575(CHEMBL1934319)
Affinity DataIC50: 2.10nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484559(CHEMBL1934165)
Affinity DataIC50: 2.70nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484557(CHEMBL1934163)
Affinity DataIC50: 2.90nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484562(CHEMBL1934171)
Affinity DataIC50: 3.5nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484582(CHEMBL1934178)
Affinity DataIC50: 3.5nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484574(CHEMBL1934193)
Affinity DataIC50: 3.70nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484583(CHEMBL1934183)
Affinity DataIC50: 4.20nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484561(CHEMBL1934168)
Affinity DataIC50: 5.70nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484573(CHEMBL1934192)
Affinity DataIC50: 8.90nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484580(CHEMBL1934170)
Affinity DataIC50: 11nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484565(CHEMBL1934177)
Affinity DataIC50: 12nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484576(CHEMBL1934169)
Affinity DataIC50: 13nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484564(CHEMBL1934176)
Affinity DataIC50: 15nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484566(CHEMBL1934179)
Affinity DataIC50: 17nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484586(CHEMBL1934174)
Affinity DataIC50: 20nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484587(CHEMBL1934189)
Affinity DataIC50: 20nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM152739(5-(4-chlorophenyl)benzo[c]2,6-naphthyridine-8-carb...)
Affinity DataIC50: 30nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484560(CHEMBL1934167)
Affinity DataIC50: 34nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484585(CHEMBL1934162)
Affinity DataIC50: 35nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484581(CHEMBL1934175)
Affinity DataIC50: 39nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
LigandPNGBDBM50365463(CHEMBL1232461)
Affinity DataKd:  46nMAssay Description:Binding affinity against CSNK2B (unknown origin) assessed as apparent dissociation constant incubated for 1 hr by colloidal coomassie staining based ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM218931(US9303033, G8, Table 22A, Compound 27 | US9303033,...)
Affinity DataIC50: 48.7nMpH: 7.0Assay Description:5 uM ATP: Test compounds dissolved and diluted in DMSO (2 μl) were added to a reaction mixture comprising 10 μl of 5× Reaction Buffer (40 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2017
Entry Details
US Patent

LigandPNGBDBM218937(US9303033, T7, Table 22A, Compound 14 | US9303033,...)
Affinity DataIC50: 48.7nMpH: 7.0Assay Description:5 uM ATP: Test compounds dissolved and diluted in DMSO (2 μl) were added to a reaction mixture comprising 10 μl of 5× Reaction Buffer (40 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2017
Entry Details
US Patent

LigandPNGBDBM218923(US9303033, D8, Table 22A, Compound 24 | US9303033,...)
Affinity DataIC50: 75.4nMpH: 7.0Assay Description:5 uM ATP: Test compounds dissolved and diluted in DMSO (2 μl) were added to a reaction mixture comprising 10 μl of 5× Reaction Buffer (40 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2017
Entry Details
US Patent

LigandPNGBDBM218935(US9303033, K8, Table 22A, Compound 31 | US9303033,...)
Affinity DataIC50: 75.4nMpH: 7.0Assay Description:5 uM ATP: Test compounds dissolved and diluted in DMSO (2 μl) were added to a reaction mixture comprising 10 μl of 5× Reaction Buffer (40 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2017
Entry Details
US Patent

TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50530315(CHEMBL4520531)
Affinity DataKi:  86nMAssay Description:ATP competitive inhibition of recombinant human CK2alpha2 (1 to 335 residues)/CK2beta2 (1 to 193 residues) expressed in Escherichia coli BL21(DE3) us...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
LigandPNGBDBM50652793(CHEMBL5653589)
Affinity DataKd:  89nMAssay Description:Binding affinity to human CSNK2B incubated for 45 mins by Kinobead based pull down assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM50365463(CHEMBL1232461)
Affinity DataIC50: 100nMAssay Description:Inhibition of CSNK2B (unknown origin) incubated for 1 hr by colloidal coomassie staining based LC-MS/MS analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
TBA
Entry Details
PubMed
LigandPNGBDBM50652792(CHEMBL3752910)
Affinity DataKd:  109nMAssay Description:Binding affinity to human CSNK2B incubated for 45 mins by Kinobead based pull down assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
TBA
Entry Details
PubMed
TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50484572(CHEMBL1934190)
Affinity DataIC50: 164nMAssay Description:Inhibition of human recombinant CK2alpha/CK2beta using RRRDDDSDDD peptide as substrate by radiometric assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/29/2020
Entry Details Article
PubMed
LigandPNGBDBM218955(US9303033, J5, Table 15A, Compound 3)
Affinity DataIC50: 198nMpH: 7.0Assay Description:5 uM ATP: Test compounds dissolved and diluted in DMSO (2 μl) were added to a reaction mixture comprising 10 μl of 5× Reaction Buffer (40 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2017
Entry Details
US Patent

TargetCasein kinase II subunit alpha'/beta(Human)
Cylene Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50540033(CHEMBL4635554)
Affinity DataKi:  206nMAssay Description:ATP competitive inhibition of recombinant human CK2alpha2 (1 to 335 residues)/CK2beta2 (1 to 193 residues) expressed in Escherichia coli BL21(DE3) us...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/12/2021
Entry Details Article
PubMed
LigandPNGBDBM218973(US9303033, A6, Table 18A, Compound 4)
Affinity DataIC50: 209nMpH: 7.0Assay Description:5 uM ATP: Test compounds dissolved and diluted in DMSO (2 μl) were added to a reaction mixture comprising 10 μl of 5× Reaction Buffer (40 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2017
Entry Details
US Patent

LigandPNGBDBM218954(US9303033, I5, Table 15A, Compound 2)
Affinity DataIC50: 218nMpH: 7.0Assay Description:5 uM ATP: Test compounds dissolved and diluted in DMSO (2 μl) were added to a reaction mixture comprising 10 μl of 5× Reaction Buffer (40 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2017
Entry Details
US Patent

LigandPNGBDBM218886(US9303033, O36, Table 41A, Compound 1 | US9303033,...)
Affinity DataIC50: 253nMpH: 7.0Assay Description:Test compounds dissolved and diluted in DMSO (2 μl) were added to a reaction mixture comprising 10 μl of 5× Reaction Buffer (40 mM MOPS pH ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2017
Entry Details
US Patent

LigandPNGBDBM218925(US9303033, F8, Table 22A, Compound 26 | US9303033,...)
Affinity DataIC50: 256nMpH: 7.0Assay Description:5 uM ATP: Test compounds dissolved and diluted in DMSO (2 μl) were added to a reaction mixture comprising 10 μl of 5× Reaction Buffer (40 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2017
Entry Details
US Patent

LigandPNGBDBM218936(US9303033, S7, Table 22A, Compound 13 | US9303033,...)
Affinity DataIC50: 256nMpH: 7.0Assay Description:5 uM ATP: Test compounds dissolved and diluted in DMSO (2 μl) were added to a reaction mixture comprising 10 μl of 5× Reaction Buffer (40 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2017
Entry Details
US Patent

LigandPNGBDBM218885(US9303033, Q2, Table 9A, Compound 2)
Affinity DataIC50: 284nMpH: 7.0Assay Description:5 uM ATP: Test compounds dissolved and diluted in DMSO (2 μl) were added to a reaction mixture comprising 10 μl of 5× Reaction Buffer (40 m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/30/2017
Entry Details
US Patent

Displayed 1 to 50 (of 1026 total ) | Next | Last >>
Jump to: